CELLVERA
DEAD

Serial Number

97150676

Owner

AiPharma Global Holdings LLC

Attorney

Michael G Shariff

Filing Date

Dec 1, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CELLVERA Trademark

Serial Number: 97150676

CELLVERA is a trademark filed by AiPharma Global Holdings LLC on December 1, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

AiPharma Global Holdings LLC (2 trademarks)

Dubai , AE

Entity Type: 16

Trademark Details

Filing Date

December 1, 2021

Registration Date

Not Registered

Goods & Services

Drugs and pharmaceuticals both solids and liquid; Pharmaceutical preparations, used internally as pills and other solids, and also used as sprays and liquids, for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores, and for the treatment and prevention of diabetes; Pharmaceutical preparations, namely, anti-infectives for use in or as chemotherapeutics; pharmaceutical preparations for the treatment of viral diseases for use in or as chemotherapeutics; Disinfectants; Sanitizing preparations for household, commercial, and hospital use; all purpose disinfectants for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores

Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical drug development services; Development of pharmaceutical preparations and medicines for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores, and for the treatment and prevention of diabetes; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Testing of pharmaceuticals

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jan 23, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jan 20, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 20, 2023 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 27, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jun 27, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jun 27, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 24, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 6, 2021 NWOS
NEW APPLICATION ENTERED
Dec 4, 2021 NWAP